Resources

In part 3 of this Exclusive Interview, Dr. Emily Seto talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the challenges within the patient use of technology.

In part 4 of this Exclusive Interview, Dr. Emily Seto talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the future of mobile health technology and coming up with new ideas.

In part 5 of this Exclusive Interview, Dr. Emily Seto talks with Diabetes in Control Publisher Steve Freed during the ADA meeting in San Diego, CA about the development of mobile health technology.

In part 1 of this Exclusive Interview, Dr. Ray Kausik talks with Diabetes in Control Publisher Steve Freed during the ADA 2017 convention in San Diego, California about his work targeting PCSK9 with RNA interference to see how that impacts on lipids and clinical outcomes.

In this week's Homerun Slides, personalized treatment according to a patient's B-cell classification and common etiological factors that can be found at work across all diabetes sub-types.

The role of statins in the primary and secondary prevention of CVD has been well established. Patients with NAFLD are believed to have increased cardiovascular risk and are logical candidates for their long-term use. In accordance with their higher cardiovascular risk, the use of statins should be encouraged in patients with NAFLD but their use has remained controversial in such patients, particularly in the setting of elevated liver enzymes. Recent practice guidelines on statin use in patients with NAFLD have clearly established that they are overall safe and that they do not carry a higher risk of liver toxicity.

2017 was book-ended by the ADA: the new 2017 guidelines were the most popular article in January, and in December the 2018 guidelines took center stage. Please take a look back with us at everything that happened in between. We thank you for your readership this year, and look forward to sharing the important diabetes news of 2018.

In 2017, we offered weekly survey questions on topics ranging from standard tests, to new drugs, to opinions on CGMs, to personal exercise habits - and you answered. Here are the survey questions that drew the most response this year.

Can you name the one most-viewed DIC article in 2017? Your choices are: a) Health Benefits from Intermittent Fasting b) 1-Hour Post-Prandial Glucose Predicts Risk For Type 2 Diabetes c) New ADA 2017 Standards d) Type 1 Cured in Mice e)The Future For Insulin Pump Companies: Who Will Survive? Follow the link to see the correct answer!

With much of the U.S. in the grip of harsh winter weather as December 2017 comes to a close, we're revisiting a post we originally published in 2013 about how having diabetes or prediabetes can increase the risk of frostbite. The risk was dramatically illustrated by the experience of British explorer Sir Ranulph Fiennes, who had to pull out of a grueling expedition to cross Antarctica due to the effects of frostbite. We wish all our readers a healthy, safe, and warm new year!